Porcine Circoviruses Type 2 and 3 Chimeric Novel Vaccine Candidate Formed Virus‐Like Particles and Induced Robust Immune Response in Mice
Transboundary and Emerging Diseases · 2026-01 · 2026 (1)
DOI: 10.1155/tbed/4119771 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 17.11.2026. Verfasst von Thu-Dung Doan und 5 weiteren Autor:innen. Beteiligte Einrichtung: International Degree Program in Animal Vaccine Technology, International College, National Pingtung University of Science and Technology, Pingtung, T…. Hauptthemen laut MEDLINE: Circovirus, Viral Vaccines, Circoviridae Infections, Vaccines, Virus-Like Particle. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Industry-Academia Collaboration Plan.
Abstract (Originalsprache)
Porcine circovirus (PCV)‐associated disease (PCVAD) encompasses a range of clinical syndromes in pigs, including wasting, reproductive failure, enteritis, and respiratory disorders. These clinical manifestations are primarily associated with PCV type 2 (PCV2). However, the recently emerged PCV type 3 (PCV3) shares limited sequence identity with PCV2, which may explain the limited cross‐protection provided by current PCV2‐based commercial vaccines. In this study, we developed and evaluated a novel chimeric vaccine candidate targeting both PCV2 and PCV3. A chimeric capsid protein (rCapC) was rationally designed by replacing the decoy epitope and CD‐loop region of the PCV2 capsid with a type‐specific epitope derived from PCV3. The recombinant protein was expressed using a baculovirus expression system and verified by sodium dodecyl sulfate polyacrylamide gel (SDS‐PAGE) and Western blot analysis. rCapC was predominantly detected in the insoluble fraction of Sf9 insect cell lysates and was capable of self‐assembling into virus‐like particles (VLPs), as confirmed by transmission electron microscopy (TEM). The antigenicity of rCapC was demonstrated by an in vitro Western blot assay, showing specific reactivity with antibodies from PCV2‐infected pigs. Immunization studies in mice revealed that rCapC elicited strong and sustained humoral immune responses, persisting for up to 16 weeks post‐vaccination. Notably, the chimeric protein induced antigen‐specific anti‐PCV2 and anti‐PCV3 binding antibody responses at low antigen doses (5–25 µg per dose). These findings indicate that rCapC is a promising chimeric VLP‐based vaccine candidate capable of inducing robust bivalent humoral and cellular immune responses against both PCV2 and PCV3 Cap antigens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Degree Program in Animal Vaccine Technology, International College, National Pingtung University of Science and Technology, Pingtung, Taiwan, npust.edu.tw.
- Innovative Bioproducts Technical Service Center, National Pingtung University of Science and Technology, Pingtung, 91201, Taiwan, npust.edu.tw.
- General Research Service Center, National Pingtung University of Science and Technology, Pingtung, 91201, Taiwan, npust.edu.tw.
ORCID-Profile: Thu-Dung Doan, Stella Pranoto, Minh Tung Tran, Chet Narayan Gyawali, Hsing-Chieh Wu, Chun-Yen Chu
Förderung
- Industry-Academia Collaboration Plan
Zitieren
APA
Doan, T. D., Pranoto, S., Tran, M. T., Gyawali, C. N., Wu, H. C., & Chu, C. Y. (2026). Porcine Circoviruses Type 2 and 3 Chimeric Novel Vaccine Candidate Formed Virus‐Like Particles and Induced Robust Immune Response in Mice. Transboundary and Emerging Diseases, 2026(1). https://doi.org/10.1155/tbed/4119771
Vancouver
Doan TD, Pranoto S, Tran MT, Gyawali CN, Wu HC, Chu CY. Porcine Circoviruses Type 2 and 3 Chimeric Novel Vaccine Candidate Formed Virus‐Like Particles and Induced Robust Immune Response in Mice. Transboundary and Emerging Diseases. 2026;2026(1). doi:10.1155/tbed/4119771
BibTeX
@article{Doan2026,
author = {Doan, Thu-Dung and Pranoto, Stella and Tran, Minh Tung and Gyawali, Chet Narayan and Wu, Hsing-Chieh and Chu, Chun-Yen},
title = {Porcine Circoviruses Type 2 and 3 Chimeric Novel Vaccine Candidate Formed Virus‐Like Particles and Induced Robust Immune Response in Mice},
journal = {Transboundary and Emerging Diseases},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/tbed/4119771}
}
EUVIMED